Supplier
EQL Pharma AB
Lund · SWE
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
Awards
4
Total awarded
—
4 joint award(s) counted pro rata
Buyers
2
Sectors
1
USt-IdNr. SE556713342501
Contracts this supplier holds that are running out
14 Jan 2027
estimatedLääkevalmisteet ja niihin rinnastettavat tuotteet hankintakaudelle 1.1.2026-31.12.2027—Pohjois-Pohjanmaan hyvinvointialue2care4 Aps, filial, Abacus Medicine A/S, Abboxia AB +139 more
- DKK 211,000,000
31 Mar 2030
stated - DKK 503,000
31 Mar 2030
stated - —
31 Mar 2030
stated
Awards
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| Udbudsnummer 8 | Amgros I/S | EQL Pharma AB, Orifarm Generics A/S | — | 26 Oct 2026 |
| Udbudsnummer 2 | Amgros I/S | 2care4 Generics ApS, EQL Pharma AB | DKK 503,000 | 22 Oct 2026 |
| Udbudsnummer 1 | Amgros I/S | Devatis GmbH, EQL Pharma AB, Glenmark Pharmaceuticals Nordic AB +5 more | DKK 211,000,000 | 21 Sept 2026 |
| Lääkevalmisteet ja niihin rinnastettavat tuotteet hankintakaudelle 1.1.2026-31.12.2027 | Pohjois-Pohjanmaan hyvinvointialue | 2care4 Aps, filial, Abacus Medicine A/S, Abboxia AB +139 more | — | 7 Sept 2026 |